HealthSouth Corporation (HLS) Position Lifted by Mesirow Financial Investment Management Equity Management

Mesirow Financial Investment Management Equity Management boosted its position in shares of HealthSouth Corporation (NYSE:HLS) by 8.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 38,150 shares of the company’s stock after purchasing an additional 3,115 shares during the period. Mesirow Financial Investment Management Equity Management’s holdings in HealthSouth Corporation were worth $1,769,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the stock. Fortaleza Asset Management Inc. grew its holdings in HealthSouth Corporation by 99.3% during the 3rd quarter. Fortaleza Asset Management Inc. now owns 4,727 shares of the company’s stock valued at $219,000 after purchasing an additional 2,355 shares during the last quarter. Copeland Capital Management LLC grew its holdings in HealthSouth Corporation by 0.4% during the 3rd quarter. Copeland Capital Management LLC now owns 572,702 shares of the company’s stock valued at $26,545,000 after purchasing an additional 2,172 shares during the last quarter. Crossmark Global Holdings Inc. bought a new position in HealthSouth Corporation during the 3rd quarter valued at about $6,462,000. Heartland Advisors Inc. bought a new position in HealthSouth Corporation during the 3rd quarter valued at about $223,000. Finally, Aperio Group LLC grew its holdings in HealthSouth Corporation by 10.6% during the 3rd quarter. Aperio Group LLC now owns 23,401 shares of the company’s stock valued at $1,085,000 after purchasing an additional 2,236 shares during the last quarter. Institutional investors own 93.76% of the company’s stock.

HealthSouth Corporation (NYSE:HLS) traded down $0.73 during trading on Friday, reaching $48.50. 819,900 shares of the company’s stock traded hands, compared to its average volume of 919,424. HealthSouth Corporation has a 12 month low of $38.24 and a 12 month high of $49.99. The stock has a market cap of $4,768.08, a PE ratio of 17.38, a price-to-earnings-growth ratio of 1.78 and a beta of 0.52. The company has a debt-to-equity ratio of 1.89, a quick ratio of 1.34 and a current ratio of 1.34.

HealthSouth Corporation (NYSE:HLS) last announced its quarterly earnings results on Thursday, October 26th. The company reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.65 by $0.01. HealthSouth Corporation had a net margin of 6.69% and a return on equity of 22.81%. The firm had revenue of $995.60 million during the quarter, compared to analysts’ expectations of $985.75 million. During the same quarter in the prior year, the company earned $0.65 EPS. The company’s revenue was up 7.4% compared to the same quarter last year. research analysts predict that HealthSouth Corporation will post 2.72 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, January 16th. Stockholders of record on Tuesday, January 2nd will be given a $0.25 dividend. The ex-dividend date of this dividend is Friday, December 29th. This represents a $1.00 annualized dividend and a dividend yield of 2.06%. HealthSouth Corporation’s payout ratio is presently 36.36%.

HLS has been the topic of several analyst reports. ValuEngine downgraded shares of HealthSouth Corporation from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Stephens initiated coverage on shares of HealthSouth Corporation in a report on Thursday, August 31st. They set an “overweight” rating and a $53.00 price target on the stock. Piper Jaffray Companies reiterated a “hold” rating and set a $50.00 price target on shares of HealthSouth Corporation in a report on Sunday, September 17th. Zacks Investment Research raised shares of HealthSouth Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, October 11th. Finally, KeyCorp reissued a “hold” rating on shares of HealthSouth Corporation in a research report on Thursday, September 7th. Two analysts have rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $51.75.

WARNING: This article was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another site, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The legal version of this article can be read at https://www.dispatchtribunal.com/2017/11/12/healthsouth-corporation-hls-position-raised-by-mesirow-financial-investment-management-equity-management.html.

In other HealthSouth Corporation news, Director Yvonne M. Curl purchased 1,000 shares of the stock in a transaction dated Wednesday, November 1st. The stock was purchased at an average price of $45.95 per share, with a total value of $45,950.00. Following the transaction, the director now owns 64,144 shares of the company’s stock, valued at $2,947,416.80. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 1.60% of the stock is currently owned by corporate insiders.

HealthSouth Corporation Profile

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Institutional Ownership by Quarter for HealthSouth Corporation (NYSE:HLS)

Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply